Cervical Cancer Symptoms and Treatment

Identifying Women With HPV Improves Early Intervention

ruzik_tuzik — Fri, 14 Nov 2008 23:21:07 -0600

As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.

Merck's HPV Vaccine Gardasil Shows Potential For Men

hareyan — Fri, 14 Nov 2008 09:11:36 -0600

Merck & Co has presented data on Gardasil which shows that the vaccine, which is approved for cervical cancer, is also effective in the prevention of human papillomavirus-related disease in young men.

Data from a Phase III trial in men aged 16 to 26,which was presented at the European Research Organisation on Genital Infection and Neoplasia meeting in Nice, France, showed that Gardasil prevented 90% of external genital lesions caused by human papillomavirus types 6, 11, 16 and 18. These are the only data evaluating efficacy of any HPV vaccine in preventing disease in males, Merck noted.

Cervical Cancer Vaccine To Be Extended

ruzik_tuzik — Mon, 03 Nov 2008 03:55:18 -0600

All girls who were born between 1 September 1990 and 31 August 1991 will be offered the human papillomavirus (HPV) vaccine to protect them against the viruses that are the most common cause of cervical cancer, Health Minister Edwina Hart has announced today.

This is in addition to the routine vaccination programme that has been introduced for all 12 and 13 year old girls this year and the catch-up campaign planned for the next two years.

MRI Technique May Identify Cervical Cancer Early

ruzik_tuzik — Mon, 27 Oct 2008 07:18:48 -0500

Using high-resolution magnetic resonance imaging (MRI) with a special vaginal coil, a technique to measure the movement of water within tissue, researchers may be able to identify cervical cancer in its early stages, according to a new study being published in the November issue of Radiology.

The new technique offers better imaging of smaller tumors and may also improve surgical options when fertility-sparing procedures are being considered.

One in Four Teenage Girls Receives HPV Vaccine

hareyan — Thu, 23 Oct 2008 04:18:16 -0500

One in four teenage girls has begun the process of vaccination against human papillomavirus (HPV) with the three-shot series of Gardasil, according to the 2007 National Immunization Survey-Teen. In March 2007 the Advisory Committee on Immunization Practices (ACIP) recommended that all girls age 11 or 12 be routinely vaccinated with three doses of quadrivalent HPV vaccine. The new survey was the first official government report on compliance.

New HPV Vaccine Requirement Needed

ruzik_tuzik — Mon, 29 Sep 2008 10:51:24 -0500

Some immigrant and women's rights advocacy groups are raising concern about a new U.S. Citizenship and Immigration Services rule that adds the human papillomavirus vaccine to the list of required vaccinations for female immigrants seeking U.S. citizenship, the Dallas Morning News reports.

HPV Test Designed For Rural Areas

hareyan — Mon, 22 Sep 2008 08:06:01 -0500

A new HPV test showed to be accurate, fast and cheap and will be soon widely acceptable in rural areas. This will help women in developing countries to earlier diagnose viruses causing cervical cancer.

Cervical cancer is the number two cancer in women, with 500000 newly diagnosed cases and 300000 deaths each year. In most cases (more than 85%) it occurs in developing world. Human Papilloma Virus (HPV) is a type of infection occurring on cervix and later causing genital warts, cervical and other cancers. The sooner HPV is diagnosed, the lower cervical cancer risk is.

HPV test for developing countries shows high accuracy in predicting cervical disease

hareyan — Mon, 22 Sep 2008 00:20:04 -0500

QIAGEN's careHPV test provides 'substantially more accurate' front-line screening.

A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. The first published study of patient outcomes with QIAGEN's careHPV test – developed with support from PATH, a non-profit global health organization – appears in the October issue of Lancet Oncology.

HPV Vaccine Protects Women Against Cervical Cancer

ruzik_tuzik — Tue, 16 Sep 2008 08:54:35 -0500

For the second year, Toronto Public Health is offering the Human Papillomavirus (HPV) vaccine, free of charge, to protect young women against cervical cancer. HPV is a common virus that can cause cancer of the cervix and genital warts.

The vaccine will be administered to Grade 8 girls at school-based vaccination clinics beginning September 17. Three doses of the vaccine are required for protection. Girls who are starting Grade 9 and missed their second or third dose of the HPV vaccine can still get vaccinated at a Toronto Public Health catch-up clinic.

Northern Ireland Launches Cervical Cancer Vaccination Program

ruzik_tuzik — Thu, 04 Sep 2008 10:01:55 -0500

The programme to immunise girls against the Humanpapillomavirus (HPV) which can cause cervical cancer was officially launched today.

Starting this month, the vaccine which protects against the two strains of the virus that cause around 70% of cervical cancer cases will be routinely offered to girls aged 12-13 in schools across Northern Ireland.